title: One-year comparison of a high-monounsaturated fat diet with a high-carbohydrate diet in type 2 diabetes.
abstract: OBJECTIVE
  The purpose of this study was to compare the effects of high-monounsaturated fatty acid (MUFA) and high-carbohydrate (CHO) diets on body weight and glycemic control in men and women with type 2 diabetes.
  
  
  METHODS
  Overweight/obese participants with type 2 diabetes (n = 124, age = 56.5 +/- 0.8 years, BMI = 35.9 +/- 0.3 kg/m2, and A1C = 7.3 +/- 0.1%) were randomly assigned to 1 year of a high-MUFA or high-CHO diet. Anthropometric and metabolic parameters were assessed at baseline and after 4, 8, and 12 months of dieting.
  
  
  RESULTS
  Baseline characteristics were similar between the treatment groups. The overall retention rate for 1 year was 77% (69% for the high-MUFA group and 84% for the high-CHO group; P = 0.06). Based on food records, both groups had similar energy intake but a significant difference in MUFA intake. Both groups had similar weight loss over 1 year (-4.0 +/- 0.8 vs. -3.8 +/- 0.6 kg) and comparable improvement in body fat, waist circumference, diastolic blood pressure, HDL cholesterol, A1C, and fasting glucose and insulin. There were no differences in these parameters between the groups. A follow-up assessment of a subset of participants (n = 36) was conducted 18 months after completion of the 52-week diet. These participants maintained their weight loss and A1C during the follow-up period.
  
  
  CONCLUSIONS
  In individuals with type 2 diabetes, high-MUFA diets are an alternative to conventional lower-fat, high-CHO diets with comparable beneficial effects on body weight, body composition, cardiovascular risk factors, and glycemic control.
authors.affiliation: College of Nursing, University of Cincinnati, Cincinnati, Ohio, USA. bonnie.brehm@uc.edu
authors.forename: Bonnie J
authors.initials: BJ
authors.lastname: Brehm
authors.forename: Barbara L
authors.initials: BL
authors.lastname: Lattin
authors.forename: Suzanne S
authors.initials: SS
authors.lastname: Summer
authors.forename: Jane A
authors.initials: JA
authors.lastname: Boback
authors.forename: Gina M
authors.initials: GM
authors.lastname: Gilchrist
authors.forename: Ronald J
authors.initials: RJ
authors.lastname: Jandacek
authors.forename: David A
authors.initials: DA
authors.lastname: D'Alessio
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000453:epidemiology; D015930:Diet Records; D003927:Diet, Diabetic; D018752:Diet, Fat-Restricted; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005229:Fatty Acids, Monounsaturated; D005247:Feeding Behavior; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D050177:Overweight; D010349:Patient Compliance; D018579:Patient Selection
chemical_list: D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005229:Fatty Acids, Monounsaturated; D007004:Hypoglycemic Agents